Moolec Science SA (MLEC) vs Onconetix, Inc. (ONCO)
Moolec Science SA and Onconetix, Inc. are both Biotechnology companies. Moolec Science SA and Onconetix, Inc. are of similar size ($4.6M and $4.3M). Moolec Science SA has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. Moolec Science SA has the higher net margin (−7.18% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 17 metrics below, Moolec Science SA leads on 10 and Onconetix, Inc. on 7.
Valuation
Profitability
| Metric | MLEC | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 39.67% | 80.38% | 65.16% |
| Operating margin | 4.09% | (2,524.73%) | 0.00% |
| Net margin | (7.18%) | (1,578.60%) | 0.00% |
| Free cash flow margin | 0.00% | (1,595.90%) | 0.00% |
| Return on equity | 0.00% | (105.23%) | (57.72%) |
| Return on assets | 0.00% | (57.37%) | (49.22%) |
| Return on invested capital | 0.00% | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack